Medicines Distribution Consent




4154 NEW ZEALAND GAZETTE, No. 166 16 DECEMBER 2004

Product:
m-Ciprofloxacin
Active Ingredient:
Ciprofloxacin lactate 2.55mg/mL equivalent to ciprofloxacin 2mg/mL
Dosage Form:
Solution for infusion
New Zealand Sponsor:
Multichem NZ Limited
Manufacturer:
Demo SA, Kryoneri, Athens, Greece

Product:
m-Morphine
Active Ingredient:
Morphine sulphate 1mg/mL equivalent to morphine 0.752mg/mL
Dosage Form:
Solution for injection
New Zealand Sponsor:
Multichem NZ Limited
Manufacturer:
Hameln Pharmaceuticals GmbH, Hameln, Germany

Product:
m-Morphine
Active Ingredient:
Morphine sulphate 10mg/mL equivalent to morphine 7.52 mg/mL
Dosage Form:
Solution for injection
New Zealand Sponsor:
Multichem NZ Limited
Manufacturer:
Hameln Pharmaceuticals GmbH, Hameln, Germany

Product:
m-Morphine
Active Ingredient:
Morphine sulphate 15mg/mL equivalent to morphine 11.28mg/mL
Dosage Form:
Solution for injection
New Zealand Sponsor:
Multichem NZ Limited
Manufacturer:
Hameln Pharmaceuticals GmbH, Hameln, Germany

Dated this 9th day of December 2004.

DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).

go8335

Consent to the Distribution of Changed Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines which were referred to the Minister of Health under the provisions of section 24 (5) of the Act and are set out in the Schedule hereto:

Schedule

Product:
Pegasys
Active Ingredient:
Peginterferon alfa-2a 270µg/mL
Dosage Form:
Solution for injection
New Zealand Sponsor:
Roche Products (New Zealand) Limited
Manufacturer:
F Hoffmann-La Roche Limited, Basel, Switzerland

Product:
Pegasys
Active Ingredient:
Peginterferon alfa-2a 360µg/mL
Dosage Form:
Solution for injection
New Zealand Sponsor:
Roche Products (New Zealand) Limited
Manufacturer:
F Hoffmann-La Roche Limited, Basel, Switzerland

Product:
Replagal
Active Ingredient:
Agalsidase alfa 1mg/mL
Dosage Form:
Concentrate for infusion
New Zealand Sponsor:
Health Consulting Group Limited
Manufacturer:
Chesapeake Biological Laboratories Inc, Baltimore, Maryland, United States of America

Dated this 9th day of December 2004.

DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).

go8334

Consent to the Distribution of Changed Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines which were referred to the Minister of Health under the provisions of section 24 (5) of the Act and are set out in the Schedule hereto:

Schedule

Product:
Atacand
Active Ingredient:
Candesartan cilexetil 16mg
Dosage Form:
Tablet
New Zealand Sponsor:
AstraZeneca Limited
Manufacturer:
AstraZeneca AB, Södertälje, Sweden



Next Page →



Online Sources for this page:

VUW Te Waharoa PDF NZ Gazette 2004, No 166


Gazette.govt.nz PDF NZ Gazette 2004, No 166





✨ LLM interpretation of page content

🏥 Consent to the Distribution of New Medicines

🏥 Health & Social Welfare
9 December 2004
Medicines Act 1981, Distribution Consent, m-Ciprofloxacin, m-Morphine
  • DON MATHESON, Deputy Director-General, Public Health

🏥 Consent to the Distribution of Changed Medicines

🏥 Health & Social Welfare
9 December 2004
Medicines Act 1981, Distribution Consent, Pegasys, Replagal
  • DON MATHESON, Deputy Director-General, Public Health

🏥 Consent to the Distribution of Changed Medicines

🏥 Health & Social Welfare
9 December 2004
Medicines Act 1981, Distribution Consent, Atacand
  • DON MATHESON, Deputy Director-General, Public Health